Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

The Effect of Ramosetron on Remifentanil in Preventing Emergence Cough from Sevoflurane Anesthesia in Female Patients

Author(s): Ji Ho Kim, Ga Yun Lee, Hye Sun Lee* and Sung Yong Park*

Volume 28, Issue 16, 2022

Published on: 02 June, 2022

Page: [1359 - 1366] Pages: 8

DOI: 10.2174/1381612828666220412101447

Price: $65

Abstract

Background: Remifentanil reduces cough during extubation. Ramosetron, a 5-HT3 receptor antagonist, is a potent antiemetic. Regarding the antitussive property of 5-HT receptor agonists, ramosetron can mediate the cough reflex by increasing the remifentanil requirement. This study evaluated the effect of ramosetron on the optimal effect-site concentration (Ce) of remifentanil for preventing emergence cough from sevoflurane anesthesia in female patients.

Methods: Forty-seven randomly selected female patients undergoing laparoscopic cholecystectomy received either ramosetron 0.3 mg (n = 23) or the same volume of normal saline (n = 24) intravenously at the end of surgery. The remifentanil Ce using target-controlled infusion in 50% of patients (EC50) and 95% of patients (EC95) were assessed using Dixon’s up-and-down or isotonic regression method with a bootstrapping approach.

Results: Using Dixon’s up-and-down method, the EC50 of remifentanil in the control group (1.33 ± 0.38 ng/mL) was comparable to that of ramosetron group (1.50 ± 0.69 ng/mL) (P = 0.615). Using isotonic regression analysis, the EC50 (83% confidence interval) did not differ between the two groups (1.17 [0.86-1.43] ng/mL and 1.13 [0.68-1.56] ng/mL in control and ramosetron groups). However, the EC95 (95% confidence interval) was significantly lower in the control group than in the ramosetron group (1.90 [1.45-1.96] ng/mL and 2.92 [2.35-2.97] ng/mL).

Conclusion: Remifentanil Ce for preventing emergence cough was higher in the ramosetron group than in the control group. It may indicate the lowering effect of ramosetron on the antitussive activity of remifentanil.

Keywords: Anesthesia, emergence cough, extubation, female, ramosetron, remifentanil.

« Previous Next »
[1]
Kim ES, Bishop MJ. Cough during emergence from isoflurane anesthesia. Anesth Analg 1998; 87(5): 1170-4.
[http://dx.doi.org/10.1213/00000539-199811000-00036] [PMID: 9806703]
[2]
Rosato L, Avenia N, Bernante P, et al. Complications of thyroid surgery: Analysis of a multicentric study on 14,934 patients operated on in Italy over 5 years. World J Surg 2004; 28(3): 271-6.
[http://dx.doi.org/10.1007/s00268-003-6903-1] [PMID: 14961204]
[3]
van Ramshorst GH, Nieuwenhuizen J, Hop WC, et al. Abdominal wound dehiscence in adults: Development and validation of a risk model. World J Surg 2010; 34(1): 20-7.
[http://dx.doi.org/10.1007/s00268-009-0277-y] [PMID: 19898894]
[4]
Apfelbaum JL, Hagberg CA, Caplan RA, et al. Practice guidelines for management of the difficult airway: An updated report by the American society of anesthesiologists task force on management of the difficult airway. Anesthesiology 2013; 118(2): 251-70.
[http://dx.doi.org/10.1097/ALN.0b013e31827773b2] [PMID: 23364566]
[5]
Mandel JE. Considerations for the use of short-acting opioids in general anesthesia. J Clin Anesth 2014; 26(1)(Suppl.): S1-7.
[http://dx.doi.org/10.1016/j.jclinane.2013.11.003] [PMID: 24485553]
[6]
Kim HY, Lee SY, Kang S, Kim B, Moon YR, Kim JE. Effects of age on effect-site concentration of remifentanil for suppressing anesthetic emergence cough in male patients undergoing laparoscopic cholecystectomy. Clin Interv Aging 2018; 13: 1053-60.
[http://dx.doi.org/10.2147/CIA.S166423] [PMID: 29881261]
[7]
Lee SY, Jeong YY, Lee BH, Kim JE. Sex-related differences in effect-site concentration of remifentanil for preventing anesthetic emergence cough in elderly patients. Clin Interv Aging 2018; 13: 81-9.
[http://dx.doi.org/10.2147/CIA.S151476] [PMID: 29379279]
[8]
Kim HY, Moon YR, Seok S, Kim B, Kim JE, Lee SY. Comparison of sevoflurane and desflurane on effect-site concentration of remifentanil for preventing anesthetic emergence cough in elderly female patients undergoing laparoscopic cholecystectomy. Clin Interv Aging 2018; 13: 1769-77.
[http://dx.doi.org/10.2147/CIA.S174626] [PMID: 30271132]
[9]
Gan TJ, Belani KG, Bergese S, et al. Fourth consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg 2020; 131(2): 411-48.
[http://dx.doi.org/10.1213/ANE.0000000000004833] [PMID: 32467512]
[10]
Yokoi A, Mihara T, Ka K, Goto T. Comparative efficacy of ramosetron and ondansetron in preventing postoperative nausea and vomiting: An updated systematic review and meta-analysis with trial sequential analysis. PLoS One 2017; 12(10): e0186006.
[http://dx.doi.org/10.1371/journal.pone.0186006] [PMID: 28977021]
[11]
Chou YL, Mori N, Canning BJ. Opposing effects of bronchopulmonary C-fiber subtypes on cough in guinea pigs. Am J Physiol Regul Integr Comp Physiol 2018; 314(3): R489-98.
[http://dx.doi.org/10.1152/ajpregu.00313.2017] [PMID: 29187382]
[12]
Sutovská M, Nosálová G, Sutovský J, Franová S, Prisenznáková L, Capek P. Possible mechanisms of dose-dependent cough suppressive effect of Althaea officinalis rhamnogalacturonan in guinea pigs test system. Int J Biol Macromol 2009; 45(1): 27-32.
[http://dx.doi.org/10.1016/j.ijbiomac.2009.03.008] [PMID: 19447256]
[13]
Tao R, Auerbach SB. Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system. J Pharmacol Exp Ther 2002; 303(2): 549-56.
[http://dx.doi.org/10.1124/jpet.102.037861] [PMID: 12388635]
[14]
Driessen AK, Farrell MJ, Mazzone SB, McGovern AE. Multiple neural circuits mediating airway sensations: Recent advances in the neurobiology of the urge-to-cough. Respir Physiol Neurobiol 2016; 226: 115-20.
[http://dx.doi.org/10.1016/j.resp.2015.09.017] [PMID: 26455780]
[15]
Dicpinigaitis PV. Potential future therapies for the management of cough: ACCP evidence-based clinical practice guidelines. Chest 2006; 129(1)(Suppl.): 284S-6S.
[http://dx.doi.org/10.1378/chest.129.1_suppl.284S] [PMID: 16428720]
[16]
Barnes PJ. The problem of cough and development of novel antitussives. Pulm Pharmacol Ther 2007; 20(4): 416-22.
[http://dx.doi.org/10.1016/j.pupt.2006.11.001] [PMID: 17189707]
[17]
Servin FS, Billard V. Remifentanil and other opioids. Handb Exp Pharmacol 2008; 182: 283-311.
[http://dx.doi.org/10.1007/978-3-540-74806-9_14] [PMID: 18175097]
[18]
Apfel CC, Korttila K, Abdalla M, et al. IMPACT investigators. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med 2004; 350(24): 2441-51.
[http://dx.doi.org/10.1056/NEJMoa032196] [PMID: 15190136]
[19]
Watanabe T, Moriya K, Tsubokawa N, Baba H. Effect of remifentanil on postoperative nausea and vomiting: A randomized pilot study. J Anesth 2018; 32(5): 781-5.
[http://dx.doi.org/10.1007/s00540-018-2550-4] [PMID: 30206690]
[20]
Swaika S, Pal A, Chatterjee S, Saha D, Dawar N. Ondansetron, ramosetron, or palonosetron: Which is a better choice of antiemetic to prevent postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy? Anesth Essays Res 2011; 5(2): 182-6.
[http://dx.doi.org/10.4103/0259-1162.94761] [PMID: 25885385]
[21]
Kamei J. Role of opioidergic and serotonergic mechanisms in cough and antitussives. Pulm Pharmacol 1996; 9(5-6): 349-56.
[http://dx.doi.org/10.1006/pulp.1996.0046] [PMID: 9232674]
[22]
Manzke T, Guenther U, Ponimaskin EG, et al. 5-HT4(a) receptors avert opioid-induced breathing depression without loss of analgesia. Science 2003; 301(5630): 226-9.
[http://dx.doi.org/10.1126/science.1084674] [PMID: 12855812]
[23]
Wittmann M, Schaaf T, Peters I, Wirz S, Urban BW, Barann M. The effects of fentanyl-like opioids and hydromorphone on human 5-HT3A receptors. Anesth Analg 2008; 107(1): 107-12.
[http://dx.doi.org/10.1213/ane.0b013e31817342c2] [PMID: 18635474]
[24]
Choudry NB, Gray SJ, Posner J, Fuller RW. The effect of 443C81, a mu opioid receptor agonist, on the response to inhaled capsaicin in healthy volunteers. Br J Clin Pharmacol 1991; 32(5): 633-6.
[http://dx.doi.org/10.1111/j.1365-2125.1991.tb03966.x] [PMID: 1659440]
[25]
Kamei J, Katsuma K, Kasuya Y. Involvement of mu-opioid receptors in the antitussive effects of pentazocine. Naunyn Schmiedebergs Arch Pharmacol 1992; 345(2): 203-8.
[http://dx.doi.org/10.1007/BF00165737] [PMID: 1314961]
[26]
Mazzone SB, Undem BJ. Vagal afferent innervation of the airways in health and disease. Physiol Rev 2016; 96(3): 975-1024.
[http://dx.doi.org/10.1152/physrev.00039.2015] [PMID: 27279650]
[27]
Widdicombe JG. Sensory neurophysiology of the cough reflex. J Allergy Clin Immunol 1996; 98(5 Pt 2): S84-9.
[http://dx.doi.org/10.1016/S0091-6749(96)70021-0] [PMID: 8939181]
[28]
Chuaychoo B, Lee MG, Kollarik M, Undem BJ. Effect of 5-hydroxytryptamine on vagal C-fiber subtypes in guinea pig lungs. Pulm Pharmacol Ther 2005; 18(4): 269-76.
[http://dx.doi.org/10.1016/j.pupt.2004.12.010] [PMID: 15777609]
[29]
Moe AAK, McGovern AE, Mazzone SB. Jugular vagal ganglia neurons and airway nociception: A target for treating chronic cough. Int J Biochem Cell Biol 2021; 135: 105981.
[http://dx.doi.org/10.1016/j.biocel.2021.105981] [PMID: 33895353]
[30]
Stone RA, Worsdell YM, Fuller RW, Barnes PJ. Effects of 5-hydroxytryptamine and 5-hydroxytryptophan infusion on the human cough reflex. J Appl Physiol 1993; 74(1): 396-401.
[http://dx.doi.org/10.1152/jappl.1993.74.1.396]
[31]
Puyo CA, Dahms TE. Innate immunity mediating inflammation secondary to endotracheal intubation. Arch Otolaryngol Head Neck Surg 2012; 138(9): 854-8.
[http://dx.doi.org/10.1001/archoto.2012.1746] [PMID: 22986720]
[32]
Brown C, Fezoui M, Selig WM, Schwartz CE, Ellis JL. Antitussive activity of sigma-1 receptor agonists in the guinea-pig. Br J Pharmacol 2004; 141(2): 233-40.
[http://dx.doi.org/10.1038/sj.bjp.0705605] [PMID: 14691051]
[33]
Shook JE, Watkins WD, Camporesi EM. Differential roles of opioid receptors in respiration, respiratory disease, and opiate-induced respiratory depression. Am Rev Respir Dis 1990; 142(4): 895-909.
[http://dx.doi.org/10.1164/ajrccm/142.4.895] [PMID: 2171388]
[34]
Ago Y, Hasebe S, Hiramatsu N, Hashimoto H, Takuma K, Matsuda T. Psychopharmacology of combined activation of the serotonin1A and σ1 receptors. Eur J Pharmacol 2017; 809: 172-7.
[http://dx.doi.org/10.1016/j.ejphar.2017.05.035] [PMID: 28529139]
[35]
Narita N, Hashimoto K, Tomitaka S, Minabe Y. Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain. Eur J Pharmacol 1996; 307(1): 117-9.
[http://dx.doi.org/10.1016/0014-2999(96)00254-3] [PMID: 8831113]
[36]
Dickinson RS, Morjaria JB, Wright CE, Morice AH. Is opiate action in cough due to sedation? Ther Adv Chronic Dis 2014; 5(5): 200-5.
[http://dx.doi.org/10.1177/2040622314543220] [PMID: 25177477]
[37]
Johnson KB, Syroid ND, Gupta DK, et al. An evaluation of remifentanil-sevoflurane response surface models in patients emerging from anesthesia: Model improvement using effect-site sevoflurane concentrations. Anesth Analg 2010; 111(2): 387-94.
[http://dx.doi.org/10.1213/ANE.0b013e3181afe31c] [PMID: 19820241]
[38]
Manyam SC, Gupta DK, Johnson KB, et al. Opioid-volatile anesthetic synergy: A response surface model with remifentanil and sevoflurane as prototypes. Anesthesiology 2006; 105(2): 267-78.
[http://dx.doi.org/10.1097/00000542-200608000-00009] [PMID: 16871060]
[39]
Epstein RH, Maga JM, Mahla ME, Schwenk ES, Bloom MJ. Prevalence of discordant elevations of state entropy and bispectral index in patients at amnestic sevoflurane concentrations: A historical cohort study. Can J Anaesth 2018; 65(5): 512-21.
[http://dx.doi.org/10.1007/s12630-018-1085-3] [PMID: 29524200]

Rights & Permissions Print Cite
Article Metrics
18
1
© 2024 Bentham Science Publishers | Privacy Policy